← Open Payments lookup

JAMIL ALHASSAN: Open Payments

NPI 1932605300 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,183 in 43 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,349 · 2025 $2,183

Food & beverage: $2,183
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc9$714
Alkermes, Inc.6$313
Otsuka America Pharmaceutical, Inc.6$299
Vanda Pharmaceuticals Inc.6$216
ABBVIE INC.4$161
Teva Pharmaceuticals USA, Inc.3$136
E.R. Squibb & Sons, L.L.C.1$104
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$104
Axsome Therapeutics, Inc.1$95
Braeburn Inc.1$24

Products named: INVEGA SUSTENNA, SPRAVATO, FANAPT, VRAYLAR, VIVITROL, REXULTI, UZEDY, ABILIFY MAINTENA.

Industry payments across AZ — which companies pay providers there.